Literature DB >> 9751260

Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome.

A Iolascon1, C Lo Cunsolo, L Giordani, R Cusano, K Mazzocco, M Boumgartner, P Ghisellini, M F Faienza, L Boni, B De Bernardi, M Conte, G Romeo, G P Tonini.   

Abstract

We studied chromosome 1p loss of heterozygosity (1p-LOH) in 53 neuroblastomas (NBs) using 15 (CA)n repeat loci, which covered a region of 90 cM. We also assessed chromosome 1p36 deletion by fluorescence in situ hybridization (FISH) on interphase nuclei. 1p-LOH was found in 19 (36%, 95% confidence interval (CI) 23-50%) NBs. We detected interstitial and large deletion in both localized and disseminated tumours and in one tumour of a patient at stage 4S. Allelic loss was frequently observed in 1p36 and 1p32 regions. In patients older than 1 year of age (53 versus 13%, P < 0.002) we detected significant chromosome 1p deletion and it was associated with MYCN amplification (P = 0.001). Overall survival (OS) analysis showed that 1p-LOH is predictive of a poor outcome (odds ratio 16.5, 95% CI 5.4-50.9%); therefore, 1p-LOH should be regarded as an additional tumour progression marker in neuroblastoma.

Entities:  

Mesh:

Year:  1998        PMID: 9751260     DOI: 10.1016/s0304-3835(98)00122-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

Review 1.  Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.

Authors:  J Mora; N K Cheung; B H Kushner; M P LaQuaglia; K Kramer; M Fazzari; G Heller; L Chen; W L Gerald
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  A unique role of the DNA fragmentation factor in maintaining genomic stability.

Authors:  Bin Yan; Huili Wang; Yuanlin Peng; Ye Hu; He Wang; Xiuwu Zhang; Qi Chen; Joel S Bedford; Mark W Dewhirst; Chuan-Yuan Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.

Authors:  Paola Scaruffi; Stefano Parodi; Katia Mazzocco; Raffaella Defferrari; Vincenzo Fontana; Stefano Bonassi; Gian Paolo Tonini
Journal:  Mol Diagn       Date:  2004

4.  Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas.

Authors:  A Iolascon; L Giordani; A Borriello; R Carbone; A Izzo; G P Tonini; C Gambini; F Della Ragione
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.